Linking market authorizations of medicines with disease burden in South Africa

References

• GBD Compare | IHME Viz Hub. http://vizhub.healthdata.org/gbd-compare. Accessed Apr 10, 2019.
   Google Scholar
• Wiysonge C. People in Africa are living longer but diseases of lifestyle are on the rise. Africa Health J; 2016
   Google Scholar
• Writer S. This is what’s killing South Africans? and future diseases to watch out for. 2019; https://businesstech.co.za/news/lifestyle/309292/this-is-whats-killing-south-africans-and-future-diseases-to-watch-out-for/. Accessed Apr 19, 2019.
   Google Scholar
• Mayosi BM, Lawn JE, Van Niekerk A, Bradshaw D, Karim SSA, Coovadia HM, et al. Health in South Africa: changes and challenges since 2009. Lancet. 2012;380(9858):2029–43.
   PubMed Web of Science ®Google Scholar
• Chopra M, Daviaud E, Pattinson R, Fonn S, Lawn JE. Saving the lives of South Africa’s mothers, babies, and children: can the health system deliver? Lancet. 2009;374(9692):835–46.
   PubMed Web of Science ®Google Scholar
• Chopra M, Lawn JE, Sanders D, Barron P, Karim SSA, Bradshaw D, et al. Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet. 2009;374(9694):1023–31.
   PubMed Web of Science ®Google Scholar
• Nojilana B, Bradshaw D, Pillay-van Wyk V, Msemburi W, Somdyala N, Joubert JD, et al. Persistent burden from non-communicable diseases in South Africa needs strong action. S Afr Med J. 2016;106(5):436–7.
   Web of Science ®Google Scholar
• Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009;374(9693):934–47.
   PubMed Web of Science ®Google Scholar
• MRC National Burden of Disease Study - Research Highlights. 2016; http://www.mrc.ac.za/intramural-research-units/BOD-research-highlights. Accessed Apr 7 2019.
   Google Scholar
• Masini T, Hauser J, Kuwana R, Nhat Linh N, Jaramillo E. Will regulatory issues continue to be a major barrier to access to bedaquiline and delamanid? Eur Respir J. 2018.https://doi.org/10.1183/13993003.02480-.2017.
   PubMed Web of Science ®Google Scholar
• Leng HM, Sanders D, Pollock AP. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines. GaBI J. 2015;4(2):58–63.
   Google Scholar
• Leng HMJ, Sanders D, Pollock AM. The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa: in practice-issues in public health. S Afr Med J. 2016;106(4):350–3.
   Web of Science ®Google Scholar
• Keyter A, Salek S, Banoo S, Walker SR. The South African Medicines Control Council: comparison of its registration process with Australia, Canada, Singapore and Switzerland. Front Pharmacol. 2019;10:228.
   PubMed Web of Science ®Google Scholar
• Doua JY, Geertruyden JV. Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?. Trop Med Int Health. 2014;19(1):23–36.
   PubMed Web of Science ®Google Scholar
• Stuckler D, King L, McKee M. Assessment of Medicines Regulatory Systems in sub-Saharan African Countries: An Overview of Findings from 26 Assessment Reports. 2011.
   Google Scholar
• World Health Organization. Regulatory harmonization: updating medicines regulatory systems in sub-Saharan African countries. WHO Drug Inf. 2010;24(1):6–20.
   Google Scholar
• Downing NS, Aminawung JA, Shah ND, Braunstein JB, Krumholz HM, Ross JS. Regulatory review of novel therapeutics—comparison of three regulatory agencies. N Engl J Med. 2012;366(24):2284–93.
   PubMed Web of Science ®Google Scholar
• Preston C, Valdez ML, Bond K. Strengthening medical product regulation in low- and middle-income countries. PLoS Med. 2012;9(10):e1001327.
   PubMed Web of Science ®Google Scholar
• Odedina FT, Shamley D, Okoye I, Ezeani A, Ndlovu N, Dei-Adomakoh Y, et al. Landscape of oncology clinical trials in Africa. JCO Glob Oncol. 2020;6:932–41.
   PubMedGoogle Scholar
• Laher F, Bekker L, Garrett N, Lazarus EM, Gray GE. Review of preventative HIV vaccine clinical trials in South Africa. Arch Virol 2020;1–14.
   Google Scholar
• Limaye D, Langer JM, Rühling T, Fortwengel G. A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa. BMJ Open 2015;5 (8).
   Google Scholar
• Leng HM, Sanders D, Pollock AM. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines.
   Google Scholar
• Department of Trade, Industry & Competition. Industrial Policy Action Plan, IPAP 2016/2017–2018/2019. http://www.thedtic.gov.za/wp-content/uploads/IPAP2019.pdf. Accessed 23 June, 2020.
   Google Scholar
• Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–34.
   PubMed Web of Science ®Google Scholar
• Klug H. Access to Medicines and the Transformation of the South African State. Transnational Legal Ordering and State Change 2012:148.
   Google Scholar
• Pharma company hails new medicines control body. https://www.bizcommunity.com/Article/196/398/149027.html. Accessed Jun 23, 2020.
   Google Scholar
• South African Health Products Regulatory Authority. Guidance for the submission of the South African CTD /eCTD - General & Module 1. 2019; https://www.sahpra.org.za/product-registration-process/. Accessed 23 June, 2020.
   Google Scholar
• World Health Organisation. ATC/DDD Index 2019. https://www.whocc.no/atc_ddd_index/. Accessed 25/07/, 2019.
   Google Scholar
• Keyter A, Gouws J, Salek S, Walker S. The regulatory review process in South Africa: challenges and opportunities for a new improved system. Therap Innov Regul Sci. 2018;52(4):449–58.
   PubMed Web of Science ®Google Scholar
• UNAIDS. UNAIDS report - South Africa. 2018; https://www.unaids.org/en/regionscountries/countries/southafrica. Accessed July 28, 2020.
   Google Scholar
• Somdyala NI, Bradshaw D, Dhansay MA, Stefan DC. Increasing cervical cancer incidence in rural Eastern Cape Province of South Africa From 1998 to 2012: a population-based Cancer Registry Study. JCO Glob Oncol. 2020;6:1–8.
   PubMedGoogle Scholar
• Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.
   PubMed Web of Science ®Google Scholar
• Gray A. Medicines Control Council–half a century of regulatory progress. SA Pharm J. 2018;85(1):87.
   Google Scholar
• Pheiffer C, Pillay-van Wyk V, Joubert JD, Levitt N, Nglazi MD, Bradshaw D. The prevalence of type 2 diabetes in South Africa: a systematic review protocol. BMJ Open. 2018;8(7):e021029.
   PubMed Web of Science ®Google Scholar
• Keyter A, Banoo S, Salek S, Walker SR. The South African regulatory system: past, present and future. Front Pharmacol. 2018;91407.
   PubMed Web of Science ®Google Scholar
• Disappointment as DOH delays launch of SA drug regulator. 2017; https://www.medicalbrief.co.za/archives/disappointment-doh-delays-launch-sa-drug-regulator/. Accessed Sep 9, 2020.
   Google Scholar
• South Africa may ask pharma firms for fee to clear drug review backlog. 2018; https://www.cbn.co.za/news/south-africa-may-ask-pharma-firms-for-fee-to-clear-drug-review-backlog/. Accessed Sep 9, 2020.
   Google Scholar
• Wouters OJ, Sandberg DM, Pillay A, Kanavos PG. The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. Soc Sci Med. 2019;220:362–70.
   PubMed Web of Science ®Google Scholar
• Parliamentary Monitoring Group. National Public Health Institute Bill: finalisation; High Level Panel & Legacy Reports | PMG. https://pmg.org.za/committee-meeting/28109/. Accessed Apr 7, 2019.
   Google Scholar